CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Summary

The aim of the study is to evaluate the efficacy and safety of Bemiparin, a second-generation LMWH, in the prophylaxis of VTE (using a postoperative regimen, i.e. administering the first dose 6 hours after finishing the surgical procedure) for 28 days compared to 8 days, in oncological surgery.

Timeline

Start

2005-05

Primary completion

—

Completion

2009-04

Drugs

Indications